Latest

1 story

Hide weekly roundups

Tuesday, September 1

Samsung Bioepis gets label supplement approved for Byooviz ranibizumab biosimilar

Regulatory decisionBiogen Harrow Inc

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.